COVID-19 Resources


 

Webinars


 

Publications


 

Conference Presentations


 

Podcasts


 

Alternative Specimen Collection Options

Author(s): Gudin, J, Suomala, J
Date: Wednesday, April 21, 2021
Specialties: COVID-19, Toxicology/Pain Management
Description: Today’s podcast discussion will focus on the importance of drug monitoring and the benefits of “alternative” sample collection options during the COVID-19 pandemic. Key information shared will include: - How clinical drug monitoring is a critical tool to help assess prescription compliance with controlled substances and help identify drug misuse - Situations, including the COVID-19 pandemic, when in-office collection isn't always possible - Quest Diagnostics’ offerings for alternative specimen collection options, including: - Self /At-Home collection - Patient Service Center collection - How alternative collection options can help ensure your patients get the testing they need Read more 

COVID-19: Supporting Safety for the Front Line

Author(s): Bellos, N
Date: Wednesday, April 21, 2021
Specialties: COVID-19, Infectious Disease
Description: Today’s podcast features Dr Nicholaos Bellos with strategies that are helping some health systems best operate in today's healthcare environment. In this session, Dr Bellos discusses the ease of viral transmission and what health systems can do to mitigate risk, diagnostic solutions, guidelines, and best practices to ensure safety for the front line, and the future of health systems in the post-pandemic landscape Read more 

The epidemic within the pandemic

Author(s): Gudin, J, Niles, JK
Date: Wednesday, December 30, 2020
Specialties: COVID-19, Toxicology/Pain Management
Description: Today’s podcast will share results of a recent Quest Diagnostics Health Trends™ publication, The Opioid Epidemic Within the COVID-19 Pandemic: Drug Monitoring in 2020, which was published in the October 2020 edition of Population Health Management. The study objective was to better understand the relationship between the COVID-19 pandemic and the drug epidemic in the US. To achieve this objective, investigators analyzed urine specimen results from an analytic cohort of 872,762 specimens from all 50 states and the District of Columbia. Findings demonstrated significant changes in prescription drug monitoring and positivity rates for many drugs of concern. Important study results and conclusions is discussed in this podcast episode. Read more